Efficacy and toxicity of bendamustine in patients with relapsed low-grade non-Hodgkin's lymphomas

Anti-Cancer Drugs

Volumn 12, Issue 9, 2001, Pages 725-729

  Heider, A ^a   Niederle, N ^a  

^a KLINIKUM LEVERKUSEN   (Germany)

Author keywords

Bendamustine; Chemotherapeutic pretreatment; Efficacy; Relapsed low grade non Hodgkin's lymphoma; Toxicity

Indexed keywords

BENDAMUSTINE; CYTOSTATIC AGENT;

ADULT; AGED; ARTICLE; BONE MARROW SUPPRESSION; CANCER GRADING; CANCER RECURRENCE; CANCER REGRESSION; CANCER SURVIVAL; CLINICAL TRIAL; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG TOLERABILITY; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

ADULT; AGED; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, LOW-GRADE; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NITROGEN MUSTARD COMPOUNDS; REMISSION INDUCTION; SURVIVAL ANALYSIS;

EID: 0034773457     PISSN: 09594973     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001813-200110000-00003     Document Type: Article

References (38)

1. Classification and clinical course of low-grade non-Hodgkin's lymphomas with overview of therapy
2. Current status and future perspectives in the treatment of low-grade non-Hodgkin's lymphomas
3. Rituximab (anti-CD20 monoclonal antibody) for the treatment of patients with relapsing or refractory aggressive lymphoma: A multicenter phase II study
4. IDECC2B8 (Rituximab) anti-CD20 monoclonal antibody therapy in patients with relapsed low-grade non-Hodgkin's lymphoma
5. Fludarabine in low grade lymphoma
6. Efficacy and toxicity of 2-chlorodeoxy-adenosine (cladribine) - 2 h infusion for 5 days - As first line treatment for advanced low grade non-Hodgkin's lymphomas
7. Cladribine in the treatment of advanced relapsed or refractory low and intermediate grade non-Hodgkin's lymphoma
8. Multicenter phase II study of iodine-131 tositumab for chemotherapy-relapsed/refractory low grade and transformed low-grade B-cell-nonHodgkin's lymphomas
9. Extented Rituximab (anti-CD 20 monoclonal antibody) therapy for relapsed or refractory low-grade or follicular non-Hodgkin's lymphoma
10. Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: Phase II randomized study
11. Phase I/II trial of JDEC-Y2B8 Radioimmunotherapy for treatment of relapsed or refractory CD20(+) B-cell non-Hodgkin's lymphoma
12. Zur methodik der bestimmung alkylierender aktivitäten von N-Losten mit nitrobenzylpyridin (NBP) in biologischem material
13. Imet 3393, γ-[1-Methyl 5 bis- (β-Chloräthyl)-amino-benzimidazolyl(2)]- buttersäurehydrochlorid, ein neues zytostatikum aus der reihe der benzimidazol-loste
14. Bendamustine, a low toxic nitrogen-mustard derivative with high efficacy in malignant lymphomas
15. Primäre chemotherapie des metastasierenden mammakarzinoms mit bendamustinhydrochlorid, methotrexat und fluorouracil versus cyclo-phosphamid, methotrexat und fluorouracil
16. Bendamustine as salvage treatment in patients with advanced progressive breast cancer: A phase II study
17. Chemotherapie des fortgeschrittenen nicht-kleinzelligen und kleinzelligen bronchialkarzinoms mit bendamustin - Eine phase-II-studie
18. Zur rezidivtherapie mit bendamustin bei patienten mit non Hodgkin-lymphomen vom niedrigen malignitätsgrad und plasmozytomen
19. Bendamustine in untreated small cell lung cancer (SCLC): Efficacy and toxicity
20. Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas
21. Non-parametric estimation from incomplete observations
22. Bone marrow transplantation for low-grade B-cell malignancies
23. High-dose therapy and transplantation in non-Hodgkin's lymphoma
24. Bone marrow transplantation for non-Hodgkin's lymphoma: A review
25. Non Hodgkin's lymphoma
26. Autologous bone marrow transplantation in 69 patients with a history of low-grade-B-cell non Hodgkin's lymphoma
27. High-dose therapy with peripheral blood progenitor cell transplantation in low-grade non-Hodgkin's lymphoma
28. High-dose chemotherapy with BUCY or BEAC and unpurged peripheral blood stem cell infusion in patients with low-grade non-Hodgkin's lymphoma
29. Long-term follow-up of advanced-stage low grade lymphoma patients treated upfront with high dose sequential chemotherapy and autograft
30. High dose therapy and autologous stem cell support for chemosensitive transformed low grade follicular non-Hodgkin's lymphoma: A case matched study from the European Bone Marrow Transplant Registry
31. Khn Cytostasan® (Bendamustin) in der alternativtherapie maligner non-Hodgkin-lymphome
32. Vergleichsuntersuchungen zwischen cytosan und cyclophospamid bei der chronischen lymphadenose, dem plasmozytom, der lymphogranulomatose und dem bronchialkarzinom
33. Bendamustin: Effective salvage chemotherapy in pretreated low grade Non-Hodgkin's Lymphomas (L.Gr.NHL)
34. BOP versus COP in advanced low grade non-Hodgkin's lymphomas - Results of a randomized multicenter study
35. Therapy of low grade non Hodgkin's lymphoma (NHL) with bendamustine and oral etoposide
36. Bendamustin monotherapy in advanced and refractory chronic lymphocytic leukemia (CLL)
37. Repeated administration of bendamustine: A phase I study in patients with advanced progressive solid tumours